• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AbilTo Study Finds Tele-behavioral Therapy Can Reduce Depression in Diabetic Patients

by HITC Staff 03/09/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

AbilTo Study Finds Tele-behavioral Therapy Can Reduce Depression in Diabetic Patients

AbilTo, a provider of behavioral health programs proven to improve medical outcomes and lower costs for high-risk medical populations, today announced that Telemedicine and e-Health has published the results of a study AbilTo conducted on the impact of tele-behavioral therapy on diabetes patients with depression.AbilTo’s study documents significant decreases in depression, anxiety, stress, and glucose levels, as well as increased frequency of glucose self-testing, among participants.

Depression is prevalent among individuals with diabetes and associated with suboptimal self-management. But little has been known about the feasibility and potential impact of tele-behavioral therapy to improve depressive symptoms and self-management among diabetes patients.

The March 9 article titled “A Tele-Behavioral Health Intervention to Reduce Depression, Anxiety, and Stress and Improve Diabetes Self-Management” and authored by Dr. Heidi Mochari-Greenberger et al., describes the results from 466 patients who graduated from AbilTo’s eight-week diabetes behavioral health program during a 6-month period. The care was delivered via telephone or secure video, based upon participant preference, and administered by a provider team comprised of a licensed clinical social worker and a behavior coach.

Among graduates with elevated depression, anxiety, or stress at baseline (approximately half of participants), there were significant reductions in all categories, and more than 80% of participants improved by at least one category of depression, anxiety, or stress severity.  Improved glucose self-testing frequency and significant reductions in average morning glucose levels were observed from baseline to graduation.

According to AbilTo Chief Clinical Officer and study co-author Aimee Peters, LCSW, “Programs such as AbilTo’s are effective in motivating diabetes patients to make healthy changes at a gradual pace. By fostering skills like improving and tracking food choices, participants learn the clear connection between their behaviors and stable blood glucose levels. They leave the program with a new sense of confidence and control, as well as a practical plan for sustaining their health improvements.”

In February 2015, AbilTo and Aetna published a peer-reviewed study in The American Journal of Managed Care demonstrating that a remotely delivered behavioral health intervention could improve medical health, reduce hospital admissions, and lower the cost of care for individuals with a recent cardiovascular event.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |